医療におけるジェネレーティブAIの世界市場レポート 2025年

医療におけるジェネレーティブAI市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR43.5%で40億2,000万米ドルに成長します。予測期間の成長は、高品質の医療データの利用可能性の増加、予防ヘルスケアへの注目の高まり、効率的な臨床試験のニーズの高まり、AIを強化した患者エンゲージメントツールの需要の高まり、薬剤再利用のためのAIの利用の高まりに起因すると考えられます。予測期間における主な動向には、技術の進歩、遠隔医療、個別化医療、予測分析、ウェアラブル医療技術などがあります。

医療における生成型人工知能（AI）市場の成長は、デジタル健康記録の増加によって牽引されると予想されます。デジタルカルテ、または電子カルテ（EHR）は、電子的に保存された患者の健康情報の体系的なコレクションであり、ヘルスケア環境間での共有を容易にし、患者ケアの効率と質を高める。このようなデジタルカルテの急増は、患者ケアの改善、ヘルスケア提供の効率化、規制による支援とインセンティブ、技術の進歩、患者のエンゲージメントとエンパワーメントの強化によって促進されています。医療におけるAIは、文書化の自動化、データの整理、予測的洞察の提供、パーソナライズされたサマリーの生成によってデジタルカルテを強化し、正確性、アクセシビリティ、患者ケア全体を向上させる。例えば、2024年7月、欧州委員会は、電子カルテへのアクセスが2023年の72％から2024年には79％に増加したと報告しました。このように、デジタル医療記録の増加が医療におけるジェネレーティブAI市場の成長を大きく促進しています。

この市場の主要企業は、認知評価を進め、患者ケアを改善し、メンタルヘルス管理を強化するために、脳の健康とウェルネスのためのAIソリューションなどの革新的技術の開発に注力しています。脳の健康とウェルネスのためのAIソリューションは、認知機能と心の健康を評価、監視、改善するために設計された先進技術です。例えば、2024年2月、AIを活用したデジタル治療法を専門とするカナダのDiagnaMed Holdings Corp.は、人間のメンタルヘルスとウェルネスのための初のAIソリューションであるCERVAIを発表しました。このソリューションは高度なAIを活用し、認知機能と脳の健康を総合的に評価します。認知テストや脳画像を含む様々なデータ入力を分析し、メンタルヘルス状態に関する正確な洞察を提供する最先端のアルゴリズムを備えています。このツールは、パーソナライズされた評価と実用的な推奨を提供し、認知問題の早期発見とオーダーメイドの介入を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医療におけるジェネレーティブAI PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医療におけるジェネレーティブAI市場：成長率分析
• 世界の医療におけるジェネレーティブAI市場の実績：規模と成長, 2019-2024
• 世界の医療におけるジェネレーティブAI市場の予測：規模と成長, 2024-2029, 2034F
• 世界医療におけるジェネレーティブAI総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医療におけるジェネレーティブAI市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソリューション
• サービス
• 世界の医療におけるジェネレーティブAI市場：機能別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バーチャル看護アシスタント
• ロボット支援AI手術
• 管理プロセスの最適化
• 医療画像解析
• 世界の医療におけるジェネレーティブAI市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療画像
• 創薬
• 医療診断
• 患者データ分析
• その他の用途
• 世界の医療におけるジェネレーティブAI市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 臨床調査
• ヘルスケア機関
• 診断センター
• その他のエンドユーザー
• 世界の医療におけるジェネレーティブAI市場ソリューションのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断ツール
• 治療計画システム
• パーソナライズ医療プラットフォーム
• 医薬品の発見と開発ソリューション
• 医療画像および分析ソフトウェア
• 電子健康記録（EHR）強化ツール
• 世界の医療におけるジェネレーティブAI市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 実装および統合サービス
• 研修・教育サービス
• 技術サポートとメンテナンス
• 研究開発サービス

第7章 地域別・国別分析

• 世界の医療におけるジェネレーティブAI市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医療におけるジェネレーティブAI市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医療におけるジェネレーティブAI市場：競合情勢
• 医療におけるジェネレーティブAI市場：企業プロファイル
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Veeva Systems Inc.
• Nuance Communications Inc.
• Babylon Health Ltd.
• Tempus Labs Inc.
• DeepMind Technologies Limited
• Owkin Inc.
• Viz.ai Inc.
• Recursion Pharmaceuticals Inc.
• Caresyntax Inc.
• Relay Therapeutics Inc.
• Exscientia plc
• Paige AI Inc.
• BenevolentAI Limited
• Atomwise Inc.
• Healx Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医療におけるジェネレーティブAI市場2029：新たな機会を提供する国
• 医療におけるジェネレーティブAI市場2029：新たな機会を提供するセグメント
• 医療におけるジェネレーティブAI市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative AI in medicine market size has grown exponentially in recent years. It will grow from $0.66 $ billion in 2024 to $0.95 $ billion in 2025 at a compound annual growth rate (CAGR) of 43.9%. The growth in the historic period can be attributed to a rise in computational power and machine learning algorithms, growth in precision medicine, increasing demand for drug discovery, rise in adoption of AI for diagnostic imaging, and growth in investment in AI research and development.

The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $4.02 $ billion in 2029 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to the increasing availability of high-quality medical data, growing focus on preventive healthcare, growing need for efficient clinical trials, increasing demand for AI-enhanced patient engagement tools, and rising use of AI for drug repurposing. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative ai in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative ai in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative ai in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Solutions; Service
• 2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
• 3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
• 4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Solutions: Diagnostic Tools; Treatment Planning Systems; Personalized Medicine Platforms; Drug Discovery And Development Solutions; Medical Imaging And Analysis Software; Electronic Health Record (EHR) Enhancement Tools
• 2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Technical Support And Maintenance; Research And Development Services.
• Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative AI In Medicine Market Characteristics

3. Generative AI In Medicine Market Trends And Strategies

4. Generative AI In Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative AI In Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Generative AI In Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Generative AI In Medicine Market Growth Rate Analysis
• 5.4. Global Generative AI In Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Generative AI In Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Generative AI In Medicine Total Addressable Market (TAM)

6. Generative AI In Medicine Market Segmentation

• 6.1. Global Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solutions
• Service
• 6.2. Global Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virtual Nursing Assistants
• Robot-Assisted AI Surgery
• Administrative Process Optimization
• Medical Imaging Analysis
• 6.3. Global Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Imaging
• Drug Discovery
• Medical Diagnosis
• Patient Data Analysis
• Other Applications
• 6.4. Global Generative AI In Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Clinics
• Clinical Research
• Healthcare Organizations
• Diagnostic Centers
• Other End-Users
• 6.5. Global Generative AI In Medicine Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Tools
• Treatment Planning Systems
• Personalized Medicine Platforms
• Drug Discovery And Development Solutions
• Medical Imaging And Analysis Software
• Electronic Health Record (EHR) Enhancement Tools
• 6.6. Global Generative AI In Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Implementation And Integration Services
• Training And Education Services
• Technical Support And Maintenance
• Research And Development Services

7. Generative AI In Medicine Market Regional And Country Analysis

• 7.1. Global Generative AI In Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Generative AI In Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative AI In Medicine Market

• 8.1. Asia-Pacific Generative AI In Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative AI In Medicine Market

• 9.1. China Generative AI In Medicine Market Overview
• 9.2. China Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative AI In Medicine Market

• 10.1. India Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative AI In Medicine Market

• 11.1. Japan Generative AI In Medicine Market Overview
• 11.2. Japan Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative AI In Medicine Market

• 12.1. Australia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative AI In Medicine Market

• 13.1. Indonesia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative AI In Medicine Market

• 14.1. South Korea Generative AI In Medicine Market Overview
• 14.2. South Korea Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative AI In Medicine Market

• 15.1. Western Europe Generative AI In Medicine Market Overview
• 15.2. Western Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative AI In Medicine Market

• 16.1. UK Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative AI In Medicine Market

• 17.1. Germany Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative AI In Medicine Market

• 18.1. France Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative AI In Medicine Market

• 19.1. Italy Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative AI In Medicine Market

• 20.1. Spain Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative AI In Medicine Market

• 21.1. Eastern Europe Generative AI In Medicine Market Overview
• 21.2. Eastern Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative AI In Medicine Market

• 22.1. Russia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative AI In Medicine Market

• 23.1. North America Generative AI In Medicine Market Overview
• 23.2. North America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative AI In Medicine Market

• 24.1. USA Generative AI In Medicine Market Overview
• 24.2. USA Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative AI In Medicine Market

• 25.1. Canada Generative AI In Medicine Market Overview
• 25.2. Canada Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative AI In Medicine Market

• 26.1. South America Generative AI In Medicine Market Overview
• 26.2. South America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative AI In Medicine Market

• 27.1. Brazil Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative AI In Medicine Market

• 28.1. Middle East Generative AI In Medicine Market Overview
• 28.2. Middle East Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative AI In Medicine Market

• 29.1. Africa Generative AI In Medicine Market Overview
• 29.2. Africa Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative AI In Medicine Market Competitive Landscape And Company Profiles

• 30.1. Generative AI In Medicine Market Competitive Landscape
• 30.2. Generative AI In Medicine Market Company Profiles
  • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Generative AI In Medicine Market Other Major And Innovative Companies

• 31.1. Veeva Systems Inc.
• 31.2. Nuance Communications Inc.
• 31.3. Babylon Health Ltd.
• 31.4. Tempus Labs Inc.
• 31.5. DeepMind Technologies Limited
• 31.6. Owkin Inc.
• 31.7. Viz.ai Inc.
• 31.8. Recursion Pharmaceuticals Inc.
• 31.9. Caresyntax Inc.
• 31.10. Relay Therapeutics Inc.
• 31.11. Exscientia plc
• 31.12. Paige AI Inc.
• 31.13. BenevolentAI Limited
• 31.14. Atomwise Inc.
• 31.15. Healx Ltd.

32. Global Generative AI In Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative AI In Medicine Market

34. Recent Developments In The Generative AI In Medicine Market

35. Generative AI In Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Generative AI In Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Generative AI In Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Generative AI In Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer